Bristol-Myers Squibb Company (BCBA:BMY)

Argentina flag Argentina · Delayed Price · Currency is ARS
23,600
+480 (2.08%)
At close: Sep 18, 2025
2.08%
Market Cap135.13T
Revenue (ttm)56.85T
Net Income (ttm)6.02T
Shares Outn/a
EPS (ttm)2,962.53
PE Ratio22.46
Forward PE7.01
Dividend558.83 (2.37%)
Ex-Dividend DateJul 3, 2025
Volume278
Average Volume518
Open23,130
Previous Close23,120
Day's Range22,990 - 23,690
52-Week Range16,950 - 27,225
Betan/a
RSI68.94
Earnings DateOct 30, 2025

About BCBA:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.